Previous 10 | Next 10 |
Celgene Corporation (NASDAQ: CELG) today announced that its stockholders have voted to approve the company’s proposed combination with Bristol-Myers Squibb Company (NYSE: BMY). Approximately 98% of the votes cast, and over 70% of the shares outstanding and entitled to vote, voted in f...
Celgene ( CELG ) and its partner Acceleron Pharma ( XLRN ) announced that they had submitted their BLA for their biologic luspatercept to the FDA for potential regulatory approval. The BLA to the FDA will be for two different diseases associated with anemia. In addition, a regulatory submiss...
The enigmatic Dr. Patrick Soon-Shiong has created an interminable network of companies to take on just about every major issue in healthcare. Even with billions of dollars being invested into all his subdivided family of NantWorks, we don't know if all his endeavors are going to be successful....
March monthly performance was: -0.23% More news on: IQ ARB Merger Arbitrage ETF, Red Hat, Inc., Spark Therapeutics, Inc., Read more ...
(Source: imgflip ) Like many of you, I've made plenty of investing mistakes over the years. But as long as you learn from such errors and continually improve how you run your portfolio, then achieving your long-term financial goals becomes very attainable. Recently, I explained how I've...
Let me start with a disclaimer: I am no expert in biological sciences or pharmaceutical companies. Other writers on Seeking Alpha are much more learned in this department than I, and I will leave the industry-specific analysis to them. The following article will focus on a biopharmaceutical co...
In this article, I would like to share with you some lessons that I have learned about my portfolio as a byproduct of my recent divorce. First off, divorce truly is an emotional, physical and financial earthquake. It shakes who you are as a person, and it provides forced reflection of your p...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. The week ahead sees a heavy dose of healthcare companies presenting at investor con...
From the Big Picture to Individual Stock Breakouts Last year I highlighted the Healthcare Biotech Sector Breakout and correctly forecasted "at least 20% gains in sector ETFs and even higher for many key biotech stocks in the near term." I believe the technical analysis that I will det...
News, Short Squeeze, Breakout and More Instantly...
Celgene Corporation Company Name:
CELG Stock Symbol:
NASDAQ Market:
In this clip from "The Pharma & Biotech Show" on Motley Fool Live , recorded on Feb. 2 , Motley Fool contributor Brian Orelli analyzes Gilead 's (NASDAQ: GILD) earnings report and discusses why the biotech giant could see fairly low revenue growth or even see earnings dr...
What coronavirus? Amgen 's (NASDAQ: AMGN) latest set of quarterly figures, delivered Tuesday, showed growth in the company's fundamentals during a challenging time for companies across all economic sectors. The veteran biotech company booked revenue of nearly $6.21 billion in the second qu...
It's scary out there right now for investors, with wild market swings and a lot of negative news coming out of quarterly reports. There is one sector, however, that will survive and likely thrive despite the coronavirus pandemic shutdown -- healthcare. That said, investors shouldn't head for jus...